Search research articles
Contact Us
Filters
Showing results (911-920 of 976) with videos related to
Page
of 98
Sort By:
Journal of Virology
|
December 17, 2009
Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces
Linlin Li, Amit Kapoor, Beth Slikas, et al.
JCO Precision Oncology
|
August 17, 2022
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma
Jennifer Rui Wang, Matthew Montierth, Li Xu, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 27, 2019
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer
Katherine A Hutcheson, Carla L Warneke, Christopher M K L Yao, et al.
Cancer
|
September 15, 2020
Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center
Stefanos Boukovalas, Ryan P Goepfert, J Michael Smith, et al.
Nature
|
December 23, 2011
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection
Stefanie Jäger, Dong Young Kim, Judd F Hultquist, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 6, 2019
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck
Samantha Tam, Christopher M K L Yao, Moran Amit, et al.
Cell Host & Microbe
|
June 30, 2019
ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection
Ruth Hüttenhain, Jiewei Xu, Lily A Burton, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2011
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA
Rui Xu, Anna Banka, James F Blake, et al.
The EMBO Journal
|
September 1, 2018
CRL4<sup>AMBRA1</sup> targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling
Si-Han Chen, Gwendolyn M Jang, Ruth Hüttenhain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2014
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer
Neil D Gross, Julie E Bauman, William E Gooding, et al.
Page
of 98
Search research articles
Search
Showing results (911-920 of 976) with videos related to
Sort By:
Page
of 98
Journal of Virology
|
December 17, 2009
Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces
Linlin Li, Amit Kapoor, Beth Slikas, et al.
JCO Precision Oncology
|
August 17, 2022
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma
Jennifer Rui Wang, Matthew Montierth, Li Xu, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 27, 2019
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer
Katherine A Hutcheson, Carla L Warneke, Christopher M K L Yao, et al.
Cancer
|
September 15, 2020
Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center
Stefanos Boukovalas, Ryan P Goepfert, J Michael Smith, et al.
Nature
|
December 23, 2011
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection
Stefanie Jäger, Dong Young Kim, Judd F Hultquist, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 6, 2019
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck
Samantha Tam, Christopher M K L Yao, Moran Amit, et al.
Cell Host & Microbe
|
June 30, 2019
ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection
Ruth Hüttenhain, Jiewei Xu, Lily A Burton, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2011
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA
Rui Xu, Anna Banka, James F Blake, et al.
The EMBO Journal
|
September 1, 2018
CRL4<sup>AMBRA1</sup> targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling
Si-Han Chen, Gwendolyn M Jang, Ruth Hüttenhain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2014
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer
Neil D Gross, Julie E Bauman, William E Gooding, et al.
Page
of 98